Latest Review on Antiviral Potential of Doxycycline against SARS-CoV-2
Severe acute respiratory syndrome coronavirus (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19) first emerged in Wuhan, China 1 and despite containment measures continues to spread across Asia, Southern Europe, America, and Africa. While the vaccine still seems a while away before it could reach the masses, and a large population getting infected calling for need for therapeutic modalities; many existing agents continue to be repurposed for treatment against SARS-CoV-2 infections. We review some of the most recent evidence shedding light on the antiviral effects of Doxycycline against SARS-CoV-2 infections which continue to emerge endurably over time.
Doxycycline - Promising Track Record against Community Infections
The above article has been published by Medical Dialogues under the MD Brand Connect Initiative. For more details on Doxycycline, click HERE